A new Alcon-sponsored survey conducted by Wakefield Research uncovered a gap between parental recognition of the role of ...
MarketBeat on MSN
RxSight Q2 sales sink 20% as Alcon deal bolsters 2026 outlook
Key Points Interested in RxSight, Inc.? Here are five stocks we like better. RxSight's preliminary Q2 sales fell 20% year ...
Key Points Interested in Lineage Cell Therapeutics, Inc.? Here are five stocks we like better. Lineage Cell Therapeutics ...
Despite near-term headwinds, RxSight has long-term upside from the Alcon royalty partnership, stronger margins and discounted ...
Alcon (SWX:ALC) shares are in focus after the company agreed a non exclusive collaboration with RxSight to co develop ...
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Chintan Desai has ...
You’d think keeping tabs on your contacts would be about the simplest and most straightforward task imaginable in our modern connected world — wouldn’t you? I sure would. But as I’ve learned over the ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Fagerhult Group has now completed the strategic review that was announced during the spring. The strategic plan is based on three key priorities: reducing the operating costs of the business while str ...
Detailed price information for Spyglass Pharma Inc (SGP-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results